Defects in peroxisomes such as those associated with Zellweger syndrome (ZS) can influence diverse intracellular metabolic pathways, including mitochondrial functioning. We report on an 8-month-old female infant and a 6-month-old female infant with typical clinical, radiological and laboratory features of Zellweger syndrome; light microscopic and ultrastructural evidence of mitochondrial pathology in their muscle biopsies; and homozygous pathogenic mutations of the PEX16 gene (c.460 + 5G > A) and the PEX 12 gene (c.888_889 del p.Leu297Thrfs*12), respectively. Additionally, mitochondrial respiratory chain enzymology analysis in the first girl showed a mildly low activity in complexes II-III and IV. We also review five children previously reported in the literature with a presumptive diagnosis of ZS and additional mitochondrial findings in their muscle biopsies. In conclusion, this is the first study of patients with a molecularly confirmed peroxisomal disorder with features of a concomitant mitochondrial myopathy and underscores the role of secondary mitochondrial dysfunction in Zellweger syndrome, potentially contributing to the clinical phenotype.
|Titolo:||Zellweger Syndrome coupled to secondary mitochondrial cytopathy in skeletal muscle cells in an infant: a pattern of biochemical overlapping in metabolic myopathies|
|Data di pubblicazione:||2015|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto:
|Salpietro2015_Article_ZellwegerSyndromeAndSecondaryM.pdf||Versione Editoriale (PDF)||Administrator|